I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.
A pathologist explains how semaglutide and tirzepatide work, the side effects and trade-offs he highlights, and the five-step protocol he proposes for muscle protection and stopping.
With Dr. Amin Hedayat (MD, triple board certified pathologist, clinical professor)
Key moments
Tap a moment to play the video from there.
- 0:00Framing weight loss as a tradeHedayat opens by saying that overriding an evolved biological system carries a cost, and promises a mechanism-first explanation of GLP-1 drugs.
- 2:34Evolutionary mismatch and hunger hormonesHe argues obesity reflects ancient biology in a food-rich environment, and describes ghrelin as the gas pedal and leptin as the brake.
- 6:45From venom molecule to weekly drugHe traces exendin-4 as the blueprint, then explains the amino acid change and fatty acid tail that let semaglutide last about 168 hours.
- 8:54How tirzepatide differsHedayat says tirzepatide acts on both GLP-1 and GIP receptors and often shows greater average weight loss than semaglutide in trials.
- 10:10Stomach emptying and anesthesiaHe describes nausea, bloating and rare gastroparesis, and says the American Society of Anesthesiologists issued 2023 guidance for patients on these drugs before surgery.
- 12:36Pancreas and thyroid warningsHe explains pancreatitis caution for people with existing risk factors, and the boxed thyroid warning and its link to medullary thyroid cancer or MEN 2 history.
- 14:56Muscle loss and facial changesHedayat calls muscle loss the most underrated trade-off and attributes facial changes to rapid fat loss rather than skin damage.
- 17:12Emotional flatnessHe says some people report muted joy or lower motivation, and cites preclinical and early human work on GLP-1 receptors in reward pathways.
- 18:34Why weight returns after stoppingHe cites the STEP 1 extension trial and gives three reasons for rebound: ghrelin overshoot, appetite returning before satiety, and lost muscle.
- 21:12Five-step protocol for use and exitHe lays out the protein floor, strength training, slow taper, fiber and mood monitoring, each framed as something to arrange with a physician.
What the video says
Dr. Amin Hedayat, a pathologist, presents a mechanism-first walk through GLP-1 drugs, framing weight loss on them as a trade with a biological cost. He begins with what he calls an evolutionary mismatch: he says human biology evolved to store fat during scarcity, and that the hypothalamus defends body fat with ghrelin (hunger) and leptin (fullness). In his account, obesity involves leptin resistance, which is why hunger can persist with large energy stores.
He then covers the drugs' origins and design. He describes natural GLP-1 as breaking down within about two minutes, a venom-derived molecule called exendin-4 as the blueprint for a longer-lasting version, and semaglutide as engineered with one amino acid change and a fatty acid tail so it lasts about a week. Tirzepatide, he says, adds a second target, GIP, and often produces greater average weight loss in trials, though results vary.
The middle section is a list of trade-offs. Hedayat discusses slowed stomach emptying and rare gastroparesis, why anesthesiologists need to know about these medications before surgery, pancreatitis risk in people with existing risk factors, and the boxed thyroid warning, which he says rests on preclinical findings that have not clearly carried over to humans. He also covers lean mass loss, facial volume loss that he attributes to rapid fat loss rather than drug toxicity, and a minority of people who report feeling emotionally flat.
He then explains why he says weight often returns after stopping: ghrelin overshoots, appetite returns before satiety signals, and lower muscle mass means fat regains faster. His protocol has five rules: a protein floor, strength training two to four days a week, a slow taper, fiber for mechanical fullness, and monitoring mood and motivation. He repeatedly says to work with a personal physician.
On each compound
Semaglutide7:41
Hedayat describes semaglutide as engineered with one amino acid change and a C18 fatty acid tail that binds albumin, stretching a two-minute hormone to about 168 hours. He then covers the side effects, rebound and exit protocol he associates with it.
See how your DNA reads SemaglutideTirzepatide8:54
Hedayat says tirzepatide activates both GLP-1 and GIP receptors, and that a 2022 New England Journal of Medicine comparison showed greater average weight loss than semaglutide, though he notes individual results vary. He says the GIP action may help tolerability for many patients.
See how your DNA reads Tirzepatide“Obesity is not a moral failure. It's an evolutionary success.”
What this video doesn’t settle
- It is one clinician's explanation, and the protocol he proposes is not tested here as a package against a control group.
- He gives no specific protein targets, taper schedules or dose changes, leaving them to the reader's clinician.
- The emotional flatness discussion rests on preclinical work and ongoing human studies he describes as not dramatic in most people, so how common it is remains unclear.
Questions this video answers
How does semaglutide stay active for a week?
According to Hedayat, researchers changed one amino acid so the enzyme DPP4 cannot cut the molecule, and attached a fatty acid tail that binds albumin in the blood. He says this turns a hormone that lasts about two minutes into one that lasts 168 hours.
How is tirzepatide different from semaglutide?
Hedayat says tirzepatide activates two receptors, GLP-1 and GIP, rather than only GLP-1. He says that often leads to greater average weight loss and possibly better tolerance in trials, while noting individual results vary.
Why do people regain weight after stopping GLP-1 drugs, according to this video?
Hedayat cites the STEP 1 extension trial, in which participants regained roughly two thirds of lost weight 12 months after stopping without strong lifestyle support. He gives three reasons: ghrelin overshoots, appetite returns before satiety signals, and reduced muscle mass lets fat return faster.
Why should anesthesiologists know about GLP-1 use?
Hedayat says slowed stomach emptying can leave food in the stomach even after fasting, and anesthesia removes protective airway reflexes, raising the risk of aspiration. He says this is why 2023 American Society of Anesthesiologists guidance recommends special precautions.
What protocol does Hedayat suggest for protecting muscle and stopping safely?
He proposes five rules: a protein floor, strength training two to four days a week, a slow taper, fiber for mechanical fullness, and monitoring mood and motivation. He stresses these should be arranged with a personal physician.
Video by Dr. Amin Hedayat, MD on YouTube, embedded as published. The summary is written by PeptidesDNA from the video; every claim in it is the speaker’s. Not affiliated with or endorsed by the creator. Not medical advice.
